InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-42.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by KIES PETER, Chief Financial Officer. Director active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. Aggregated, 13 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €132k. Activity tracked since 3 June 2021. The latest transaction was disclosed on 9 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
4,771 sharesCommon StockSEC:0001055726-25-000029:0
3,997 sharesCommon StockSEC:0001055726-25-000002:0
4,771 sharesCommon StockSEC:0001055726-24-000031:0
1,878 sharesCommon StockSEC:0001055726-24-000003:0
59,737 sharesCommon StockSEC:0001055726-23-000011:0
22,544 sharesCommon StockSEC:0001055726-23-000005:0
59,737 sharesCommon StockSEC:0001055726-22-000019:0
21,466 sharesCommon StockSEC:0001055726-22-000017:0
22,545 sharesCommon StockSEC:0001055726-22-000012:0
13,750 shares@ US$2.160.023% mcap26.9% of flowCommon StockSEC:0001055726-21-000050:0
13,750 shares@ US$2.1626.9% of flowCommon StockSEC:0001055726-21-000050
10,000 shares@ US$8.030.062% mcap73.1% of flowCommon StockSEC:0001055726-21-000049:0
10,000 shares@ US$8.0373.1% of flowCommon StockSEC:0001055726-21-000049
13 of 13 declarations
About KIES PETER
Peter Kies is the Chief Financial Officer at Inovio Pharmaceuticals, Inc. He oversees the financial management of the company, including budgeting and financial analysis. His role is crucial for ensuring the financial health of Inovio.
